Looking forward to this ....
Jun 05
Sunday
8:00 AM - 11:30 AM
Location: Hall A
POSTER SESSION
Developmental Therapeutics—Immunotherapy
Track(s): Developmental Therapeutics and Translational Research
Abstract TPS3108
Phase I STORM study (KEYNOTE 200): Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21 in combination with pembrolizumab in advanced cancer patients.
Poster Board: #423b
Hardev S. Pandha, MD, PhD - Presenter
University of Surrey
https://iplanner.asco.org/am2016/#/session/11294
ASCO 2016 - STORM trial update
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)